The CGM provides real-time glucose readings for 15.5 days. “As a disabled veteran living with Type 2 diabetes, becoming a grandfather has given me a powerful new reason to take charge of my health,” ...
Dexcom, a global leader in real time continuous glucose monitoring for people with diabetes, is releasing the Dexcom G6 mobile app in Spanish, available immediately for users with a compatible iOS (v1 ...
TipRanks on MSN
Citi ups DexCom target, adds 'upside 90-day catalyst watch'
Citi raised the firm’s price target on DexCom (DXCM) to $77 from $75 and keeps a Buy rating on the shares. Citi also opened an “upside 90-day catalyst watch” on DexCom. The firm sees the stock moving ...
Dexcom G7 continuous glucose monitor users can now monitor their blood sugar data in real time on an Apple Watch without having their iPhone to hand, the U.S. medical device manufacturer has announced ...
DexCom, Inc. reduced its 2024 revenue guidance following a decline in new U.S. customers and revenue per customer, leading to a sharp share price drop, despite $750 million share buyback. DexCom faces ...
DexCom, Inc. DXCM is scheduled to release fourth-quarter 2023 results on Feb 8, after the closing bell. In the last reported quarter, the company’s earnings beat estimates by 47.06%. The bottom line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback